Skip to navigation Skip to main content
  • Home
  • About us
  • Vision & Mission
  • Research Focus
    • spinal cord injury
    • neuroregeneration
    • novel molecules
    • peptide therapies
  • Projects
  • Insights
    • Articles
  • News & Updates
  • Contact us
Search
Menu

Posts by admin

16 May

Epidural Stimulation: Electrical Activation of Spinal Circuits After SCI

Epidural stimulation (ES) is an experimental neuromodulation approach in which a small array of elec...
Continue reading
16 May

Hypnosis: Exploring Its Role in Pain, Stress, and Neuropsychological Support

• Hypnosis is a psychological state characterized by focused attention, reduced peripheral awareness...
Continue reading
16 May

Thymosin β4 (TB-500): A Multifunctional Peptide in Neural and Tissue Repair

Thymosin β4 (Tβ4), also known in synthetic research form as TB-500, is a naturally occurring 43–amin...
Continue reading
16 May

Chondroitinase ABC (ChABC): Enzymatic Degradation of Inhibitory ECM After Spinal Cord Injury

Introduction After spinal cord injury (SCI), the central nervous system responds with inflammatio...
Continue reading
16 May

Axonis Therapeutics: Advancing KCC2 Modulation for Neural Recovery

Introduction Axonis Therapeutics is a biotechnology company developing first-in-class oral small-...
Continue reading
16 May

GHK-Cu: Exploring a Naturally Occurring Peptide in Tissue Repair and Wound Biology

Introduction GHK-Cu is a naturally occurring peptide–copper complex found in human plasma, saliva, ...
Continue reading
16 May

KCL-286: A Selective RARβ Agonist for Neural Repair

Introduction KCL-286 is an orally administered small-molecule drug being developed to support rep...
Continue reading
25 Feb

Pharmacologic and Cellular Approaches in Spinal Cord Injury: A Critical Overview

Article reviewed: Khalid SI et al. Pharmacologic and cellular therapies in the treatment of traumat...
Continue reading
25 Feb

New Approaches to Modulating CSPG Signaling After Spinal Cord Injury

A recent wave of studies is taking a closer look at how chondroitin sulfate proteoglycans (CSPGs) co...
Continue reading
25 Feb

A Glimpse on NVG-291 History

40 Years of Dr. Jerry Silver’s Groundbreaking Research Now Reaches SCI Patients Dr. Jerry Silver’...
Continue reading
  • 1
  • 2
  • No.6&7, 10th floor, Mellat Tower, Vali-e-Asr St, Tehran, Iran
  • +98 21 2623 0998
  • +98 912 388 3863
  • info@neuraldaroo.com
  • behrad.khalaf@gmail.com

Quick Links:

  • Research Focus
  • About Us
  • News & Updates
  • Contact Us

Location

© Neural Drug Research
  • Home
  • About us
  • Vision & Mission
  • Research Focus
    • spinal cord injury
    • neuroregeneration
    • novel molecules
    • peptide therapies
  • Projects
  • Insights
    • Articles
  • News & Updates
  • Contact us
  • Languages
    • You need WPML plugin for this to work. You can remove it from Header builder.